The Impact of Diabetes Mellitus on Patient-Reported Outcomes of Chronic Low Back Pain with Modic Changes at One Year: A Prospective Cohort Study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 37824194.
- Also identified by DOI 10.1177/21925682231206962 and PMC identifier 11877571.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prospective cohort study. Diabetes mellitus (DM) is associated with unfavourable patient-reported outcomes after spine surgery. Chronic low back pain (CLBP) with Modic Changes (MCs) in the lumbar vertebrae, as observed on MRI, forms a specific subgroup. This study aims to investigate the potential influence of DM on CLBP with MCs. This study involved 259 patients with CLBP accompanied MCs. We recorded the patient-reported outcomes (visual analogue scale (VAS), Oswestry Disability Index (ODI), and Roland-Morris Disability Questionnaire (RMDQ)) at baseline, 3, 6, and 12 months. Multivariable linear regression analyses were performed to determine predictors of patient-reported outcomes. 103 patients had DM. Patients with DM exhibited higher VAS (<i>P</i> < .05), ODI (<i>P</i> < .001), and RMDQ (<i>P</i> < .001) scores at 3, 6, and 12 months, while patients without DM experienced more significant improvements in the scores over time (<i>P</i> < .001). Patients with DM reported longer durations of physical exercise (<i>P</i> = .007). Additionally, patients without DM had a significantly higher patient satisfaction index (<i>P</i> < .001) and a lower prevalence of hypertension (<i>P</i> < .001). Notably, significant differences were observed in the distribution of MCs of lumbar vertebrae (<i>P</i> = .034) and Pfirrmann grades of intervertebral disc degeneration between two groups (<i>P</i> < .001). Patients with DM demonstrated poorer patient-reported outcomes compared to those without DM in 1-year. DM emerged as an independent predictor of adverse patient-reported outcomes. It can be utilized to enhance the management and treatment of CLBP in patients with MCs.